Evidence-graded · Source-cited Peer-reviewer panel · 6 clinicians
PeptideVox

WADA Monitored

WADA Monitored is a recurring topic in our peptide coverage. This hub collects every article tagged WADA Monitored, newest first, each evidence-graded and tied to real, verifiable sources.

Peptide Encyclopedia

Tirzepatide: Evidence, Mechanism, Dosing & Legal Status

A clinical monograph on tirzepatide — the dual GIP/GLP-1 co-agonist sold as Mounjaro and Zepbound. Grade-A RCT evidence for diabetes, obesity and sleep apnea, with a boxed warning and a tightening 2026 compounding landscape.

Peptide Encyclopedia

Semaglutide: Evidence, Mechanism, Dosing & Legal Status

A clinical monograph on semaglutide — the long-acting GLP-1 receptor agonist behind Ozempic, Wegovy and Rybelsus. Grade-A human RCT evidence across diabetes, obesity, cardiovascular, kidney and liver disease.

Peptide Encyclopedia

Exenatide in Pediatric Type 2 Diabetes: Evidence & Status

A clinical monograph on exenatide — the first-in-class GLP-1 receptor agonist (synthetic exendin-4) — with a focus on its Grade A pediatric type 2 diabetes evidence, mechanism, dosing from the literature, safety, and 2026 regulatory status.

Frequently asked

What is WADA Monitored?

WADA Monitored is a topic our editors cover across the site. This hub aggregates the related, evidence-graded guidance.

How often is the WADA Monitored hub updated?

This hub updates automatically whenever a new article is tagged WADA Monitored, so the latest coverage appears first.

Are WADA Monitored claims sourced?

Yes. Every article here grades its efficacy claims A-D and cites real, verifiable studies, regulatory documents or trial registries.

Medical Disclaimer · Read in full

PeptideVox is an evidence reference, not medical advice. Nothing here authorizes you to acquire, possess, or self-administer any compound.

01 · Not FDA-approved

The majority of compounds documented here are not approved by the FDA for human use. Approved drugs (e.g. semaglutide, tirzepatide) are noted explicitly and require a licensed prescriber.

02 · Research chemicals

Many peptides — including BPC-157 and GHK-Cu in injectable form — are sold strictly "for research use only — not for human consumption." Purity, identity, and dosing of such products are not regulated or guaranteed.

03 · WADA-prohibited

Several compounds are banned in competitive sport under the WADA Prohibited List. Athletes risk sanction regardless of intent or formulation.

04 · Consult a clinician

Always consult a qualified, licensed healthcare professional before considering any compound. Individual risk depends on your full medical context.

This content is for informational and educational purposes only · No physician–patient relationship is created · Evidence grades reflect published data as of the stated revision and may change.